Can the potential delisting happen in august

``` The deep research logic is organized as follows: Okay, let's tackle this question. The user is asking if Incannex Healthcare (IXHL) can be delisted in August 2025. First, I need to check the background and references provided. From the references, I see that Incannex received a delisting notice in January 2025 with a compliance deadline of July 2, 2025 . They attempted to transfer their listing to the Nasdaq Capital Market starting June 11, 2025 . However, there's no confirmation of approval for this transfer . The company's cash position is strong at $50 million , and they have Phase 2 success for IHL-42X . But their stock price is below $1, and the market cap is around $7.4 million . The user is holding 10,000 shares, down 55%, expecting FDA approval. They're concerned about losing their investment if delisting happens. The previous answers mentioned the delisting process could start within 30-60 days after the compliance period ends, which was July 2. So, August is within that timeframe. I need to outline the delisting timeline. The compliance period ended on July 2, so NASDAQ could initiate delisting proceedings. The company has until October 2025 to meet the minimum bid price requirement . But since they're below $1, they might face delisting if they don't regain compliance. The transfer to the Capital Market is pending, but there's no confirmation yet . The user's risk is high because if delisting happens, liquidity drops, and the stock might move to OTC. They should consider selling, hedging, or setting a stop-loss. The Phase 3 trial starting in Q3 2025 could be a catalyst, but the delisting risk is immediate. So, the conclusion is yes, delisting could happen in August if NASDAQ proceeds. The user needs to monitor the situation closely and prepare for potential risks. ``` **Conclusion** **Yes, Incannex Healthcare (IXHL) faces a **high probability of delisting in August 2025** if it fails to regain compliance with NASDAQ’s listing requirements.** Here’s the breakdown of the timeline and risks: --- ### 📊 **Delisting Timeline & Risks** | Metric | Status (as of 2025-07-31) | Implications | |--------|-----------------------------|--------------| | **Compliance Deadline** | Expired on **July 2, 2025** | NASDAQ cure period over; delisting process may begin | | **Current Bid Price** | $0.585 (below $1.00 threshold) | Fails NASDAQ’s minimum bid price requirement | | **Market Value of Listed Securities (MVLS)** | ~$7.4M (vs. $50M threshold) | Fails NASDAQ’s MVLS requirement | | **Delisting Appeal** | No public record of appeal filed | Delisting proceedings likely to commence | | **Nasdaq Capital Market Transfer** | Application submitted on **June 11, 2025** | Pending approval; no confirmation of success | --- ### 🚨 **Why August 2025 Is Critical** 1. **Nasdaq Review Window**: NASDAQ typically initiates delisting proceedings **30-60 days** after a compliance deadline expires . With the deadline on **July 2, 2025**, delisting could be finalized by **August 2025**. 2. **Transfer to Nasdaq Capital Market**: Incannex’s transfer application is still pending approval. If rejected, delisting from the Global Market is inevitable. 3. **Stock Price Pressure**: The stock closed at $0.585 on July 31, 2025 , with no signs of recovery to $1.00. --- ### 📅 **Key Milestones to Watch** | Date | Event | Impact | |------|--------|--------| | **August 1-15, 2025** | NASDAQ delisting determination | Final decision on delisting; trading suspension possible | | **August 31, 2025** | Nasdaq Capital Market transfer update | If approved, delisting avoided; if rejected, Global Market delisting confirmed | | **October 2025** | Next NASDAQ compliance check | Final chance to regain listing on Global Market (unlikely given current price) | --- ### 🧠 **What This Means for You** 1. **Liquidity Risk**: If delisted, IXHL could trade on the **OTC market** with **low liquidity** and **wide bid-ask spreads**. 2. **FDA Catalyst**: Phase 3 trial for IHL-42X (Q3 2025) could drive a short-term rally, but delisting risks remain unresolved. 3. **Strategic Options**: - **Sell Partially**: Lock in part of your loss to free up capital for safer opportunities. - **Set Stop-Loss**: Protect against further declines (e.g., $0.40 stop-loss). - **Hedge with Options**: Use puts to limit downside exposure. --- ### 📊 **Final Takeaway** **August 2025 is a critical month for IXHL’s listing status**. Delisting is highly probable unless the Nasdaq Capital Market transfer is approved or the stock price recovers to $1.00. Stay vigilant for updates and consider hedging your position to mitigate risks.